• Printer Friendly
  • Text Resizer - Small
  • Text Resizer - Large
  • Email this page

About Clinical e-Audit: Review of PPI prescribing About Clinical e-Audit: Review of PPI prescribing

Reviewing PPI prescribing

This desktop clinical e-Audit provides GPs with the opportunity to review their management of patients using proton pump inhibitors against best practice guidelines. 		NPS Clinical e-Audits

Participation will assist GPs to:

  • List the different types of ‘step-down’ strategy.
  • Clarify the dosing schedule of PPIs in the ‘step-down’ strategy.
  • Develop a systems approach to identifying patients suitable for ‘step-down’ strategy in order to minimise potential rare but serious adverse effects
  • Identify patients using a PPI for > 8 weeks with inadequate control of dyspeptic symptoms.
  • Recall which concurrent drugs can induce or exacerbate dyspepsia/ulceration (knowledge).
  • Discuss potential rare but important adverse effects of PPI with patients
  • Discuss strategies for long-term management of dyspepsia with patients.
  • Determine when to review PPI use for each clinical condition.
  • Recognise patients on maintenance use of PPI (> 8 weeks) requiring referral for investigation by endoscopy or specialist management.
     

Further information and point allocation can be viewed here.
 

Date published: 2009-09-24 00:00:00

Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.

References to brands should not be taken as an endorsement by NPS.